PCRX
Pacira BioSciences, Inc.Company with tickers: PCRX
CIK
1396814
CUSIP
695127100
Shares Outstanding
39,347,924
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $177,376,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | $36,413,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $28,072,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $6,902,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $2,916,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $0.07 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $0.07 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |